Treatment of osteo-arthropathy associated with dialysis-related amyloidosis by push/pull HDF

T. Shinzato; M. Miwa; S. Nakai; Y. Matsumoto; I. Takai; K. Maeda

Treatment of osteo-arthropathy associated with dialysis-related amyloidosis by push/pull HDF

T. Shinzato, M. Miwa, S. Nakai, Y. Matsumoto, I. Takai, K. Maeda

Research output: Contribution to journal › Article › peer-review

Abstract

Twelve long-term hemodialysis patients who complained of shoulder joint pain were selected for the present study. In these patients, cuprophane dialyzer which had been employed t date was changed to PAN-22DX hemodiafilter® (polyacrylonitrile). After hemodialysis treatment with the PAN-22DX hemodiafilter for 4 weeks, hemodialysis were switched to the push/pull HDF using the same hemodiafilter and performed for another 4 weeks. The, the treatment was switched back to hemodialysis using the PAN-22 DX hemodiafilter. The patients showed a significant increase in upper arm movement ranges following the switch to push/pull HDF treatment. The increased upper arm movement ranges were retained for nearly 2 weeks even after the switch back to the original hemodialysis. The pretreatment β₂- microglobulin concentration decreased following the switch from hemodialysis to push/pull HDF.

Original language	English
Pages (from-to)	162-164
Number of pages	3
Journal	Japanese Journal of Artificial Organs
Volume	25
Issue number	1
Publication status	Published - 1996
Externally published	Yes

All Science Journal Classification (ASJC) codes

Biophysics

Cite this

@article{9a4c2c178a3c496390c6b0bd0e0d6d34,

title = "Treatment of osteo-arthropathy associated with dialysis-related amyloidosis by push/pull HDF",

abstract = "Twelve long-term hemodialysis patients who complained of shoulder joint pain were selected for the present study. In these patients, cuprophane dialyzer which had been employed t date was changed to PAN-22DX hemodiafilter{\textregistered} (polyacrylonitrile). After hemodialysis treatment with the PAN-22DX hemodiafilter for 4 weeks, hemodialysis were switched to the push/pull HDF using the same hemodiafilter and performed for another 4 weeks. The, the treatment was switched back to hemodialysis using the PAN-22 DX hemodiafilter. The patients showed a significant increase in upper arm movement ranges following the switch to push/pull HDF treatment. The increased upper arm movement ranges were retained for nearly 2 weeks even after the switch back to the original hemodialysis. The pretreatment β2- microglobulin concentration decreased following the switch from hemodialysis to push/pull HDF.",

author = "T. Shinzato and M. Miwa and S. Nakai and Y. Matsumoto and I. Takai and K. Maeda",

year = "1996",

language = "English",

volume = "25",

pages = "162--164",

journal = "Japanese Journal of Artificial Organs",

issn = "0300-0818",

publisher = "Japanese Society for Artificial Organs and Tissues",

number = "1",

}

TY - JOUR

T1 - Treatment of osteo-arthropathy associated with dialysis-related amyloidosis by push/pull HDF

AU - Shinzato, T.

AU - Miwa, M.

AU - Nakai, S.

AU - Matsumoto, Y.

AU - Takai, I.

AU - Maeda, K.

PY - 1996

Y1 - 1996

N2 - Twelve long-term hemodialysis patients who complained of shoulder joint pain were selected for the present study. In these patients, cuprophane dialyzer which had been employed t date was changed to PAN-22DX hemodiafilter® (polyacrylonitrile). After hemodialysis treatment with the PAN-22DX hemodiafilter for 4 weeks, hemodialysis were switched to the push/pull HDF using the same hemodiafilter and performed for another 4 weeks. The, the treatment was switched back to hemodialysis using the PAN-22 DX hemodiafilter. The patients showed a significant increase in upper arm movement ranges following the switch to push/pull HDF treatment. The increased upper arm movement ranges were retained for nearly 2 weeks even after the switch back to the original hemodialysis. The pretreatment β2- microglobulin concentration decreased following the switch from hemodialysis to push/pull HDF.

AB - Twelve long-term hemodialysis patients who complained of shoulder joint pain were selected for the present study. In these patients, cuprophane dialyzer which had been employed t date was changed to PAN-22DX hemodiafilter® (polyacrylonitrile). After hemodialysis treatment with the PAN-22DX hemodiafilter for 4 weeks, hemodialysis were switched to the push/pull HDF using the same hemodiafilter and performed for another 4 weeks. The, the treatment was switched back to hemodialysis using the PAN-22 DX hemodiafilter. The patients showed a significant increase in upper arm movement ranges following the switch to push/pull HDF treatment. The increased upper arm movement ranges were retained for nearly 2 weeks even after the switch back to the original hemodialysis. The pretreatment β2- microglobulin concentration decreased following the switch from hemodialysis to push/pull HDF.

UR - http://www.scopus.com/inward/record.url?scp=0029924168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029924168&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029924168

SN - 0300-0818

VL - 25

SP - 162

EP - 164

JO - Japanese Journal of Artificial Organs

JF - Japanese Journal of Artificial Organs

IS - 1

ER -

Treatment of osteo-arthropathy associated with dialysis-related amyloidosis by push/pull HDF

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this